论文部分内容阅读
美国波士顿消息:弗洛伦斯大学的研究人员说,“小剂量肝素明显减少了6～18个月前出现过心肌梗塞的50～75岁病人的再梗塞和总的死亡率。”病人分为两组:对照组365人和肝素组363人。对照组用该研究中心的普通疗法,而肝素组注射皮下肝素钙。约9个月后,肝素组的再梗塞率比对照组低63％。通过药效和“治疗意向”分析都表明了两组累积再梗塞率的显著差异。根据药效分析和“治疗意向”分析,肝素治疗减少总累积死亡
Boston, United States: Researchers at the University of Florence say “low-dose heparin significantly reduced re-infarction and overall mortality in patients aged 50-75 years with myocardial infarction 6-18 months ago.” The patients were divided into Two groups: control group, 365 and heparin group, 363 people. The control group used the usual treatment of this research center, while the heparin group injected subcutaneous heparin calcium. About 9 months later, the reperfusion rate in the heparin group was 63% lower than in the control group. Both the efficacy and the “intention to treat” analysis showed significant differences in the cumulative re-infarct rates between the two groups. Based on pharmacodynamic analysis and “treatment intentions” analysis, heparin treatment reduced total cumulative deaths